Dyne Therapeutics, Inc.DYNNASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P23
Within normal range
vs 5Y Ago
0x
Contraction
Streak
2 qtr
Consecutive growthDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -1.84% |
| Q3 2025 | -2.03% |
| Q2 2025 | -6.77% |
| Q1 2025 | 30.12% |
| Q4 2024 | -11.85% |
| Q3 2024 | 49.05% |
| Q2 2024 | 39.79% |
| Q1 2024 | -24.31% |
| Q4 2023 | 6.50% |
| Q3 2023 | -6.56% |
| Q2 2023 | 57.53% |
| Q1 2023 | 13.09% |
| Q4 2022 | -4.27% |
| Q3 2022 | -25.70% |
| Q2 2022 | 65.26% |
| Q1 2022 | -33.25% |
| Q4 2021 | 15.86% |
| Q3 2021 | 52.94% |
| Q2 2021 | 28.17% |
| Q1 2021 | -15.72% |
| Q4 2020 | 128.31% |
| Q3 2020 | 31.97% |
| Q2 2020 | 20.45% |
| Q1 2020 | 42.97% |
| Q4 2019 | 42.82% |
| Q3 2019 | 56.99% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q4 2017 | 0.00% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q4 2016 | 0.00% |
| Q3 2016 | 0.00% |
| Q2 2016 | 0.00% |
| Q1 2016 | 0.00% |
| Q4 2015 | 0.00% |
| Q3 2015 | 0.00% |
| Q2 2015 | 0.00% |
| Q1 2015 | 0.00% |